Cargando…

Basic Verification of β-D Glucan in Leukocyte-Rich Plasma for the Diagnosis of Deep Mycosis

BACKGROUND: Currently, supplementary serological testing for β-D glucan (BDG) is often selected to diagnose deep mycosis in care covered by the health insurance in Japan. The Wako method used by our center has low sensitivity, and different studies have used different cut-off values due to factors t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimoyama, Ken, Kan, Shigenori, Takahashi, Gaku, Morino, Gota, Yamada, Yasuhiko, Inoue, Yoshihiro, Inada, Katsuya, Endo, Shigeatsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032921/
https://www.ncbi.nlm.nih.gov/pubmed/34409781
http://dx.doi.org/10.3947/ic.2020.0128
_version_ 1783676310562799616
author Shimoyama, Ken
Kan, Shigenori
Takahashi, Gaku
Morino, Gota
Yamada, Yasuhiko
Inoue, Yoshihiro
Inada, Katsuya
Endo, Shigeatsu
author_facet Shimoyama, Ken
Kan, Shigenori
Takahashi, Gaku
Morino, Gota
Yamada, Yasuhiko
Inoue, Yoshihiro
Inada, Katsuya
Endo, Shigeatsu
author_sort Shimoyama, Ken
collection PubMed
description BACKGROUND: Currently, supplementary serological testing for β-D glucan (BDG) is often selected to diagnose deep mycosis in care covered by the health insurance in Japan. The Wako method used by our center has low sensitivity, and different studies have used different cut-off values due to factors that cause false positives and false negatives. One possible cause of false negatives is the use of platelet-rich plasma (PRP) as the sample material. Because phagocytic white blood cells (WBC) are precipitated by centrifugation and only plasma is measured, it seems unlikely that the actual amount of BDG is being measured when using PRP. Further, a frequent cause of false positives is contamination from blood products and gauze containing BDG. To resolve these issues, the blood cell separator, hydroxyethyl starch, is used to precipitate only the red blood cells to obtain leukocyte-rich plasma (LRP). We hypothesized that it might be possible to improve the diagnostic rate of deep mycosis by measuring the BDG content of plasma containing WBC and fungal components and by comparing the BDG content of PRP and LRP measured simultaneously. MATERIALS AND METHODS: Healthy human blood, albumin-added blood, wrung-out gauze fluid-added blood, and fungal solution-added blood were prepared, and PRP and LRP were prepared using hydroxyethyl starch. The BDG content of each sample was measured using the Wako method and compared. In addition, PRP and LRP of fungal-added blood were Gram-stained and examined under a microscope, and the number of WBCs and phagocytosed fungi was counted visually and compared. RESULTS: Measuring the BDG content of LRP confirmed that there were no false positives with LRP, and in vitro experiments comparing albumin-added false-positive blood to fungal-added blood showed significant differences between PRP and LRP only in the fungal-added blood. CONCLUSION: Calculating the BDG-ratio (LRP/PRP) by measuring both LRP and PRP may eliminate false positives and false negatives of true deep mycosis and improve the diagnostic rate.
format Online
Article
Text
id pubmed-8032921
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS
record_format MEDLINE/PubMed
spelling pubmed-80329212021-04-15 Basic Verification of β-D Glucan in Leukocyte-Rich Plasma for the Diagnosis of Deep Mycosis Shimoyama, Ken Kan, Shigenori Takahashi, Gaku Morino, Gota Yamada, Yasuhiko Inoue, Yoshihiro Inada, Katsuya Endo, Shigeatsu Infect Chemother Original Article BACKGROUND: Currently, supplementary serological testing for β-D glucan (BDG) is often selected to diagnose deep mycosis in care covered by the health insurance in Japan. The Wako method used by our center has low sensitivity, and different studies have used different cut-off values due to factors that cause false positives and false negatives. One possible cause of false negatives is the use of platelet-rich plasma (PRP) as the sample material. Because phagocytic white blood cells (WBC) are precipitated by centrifugation and only plasma is measured, it seems unlikely that the actual amount of BDG is being measured when using PRP. Further, a frequent cause of false positives is contamination from blood products and gauze containing BDG. To resolve these issues, the blood cell separator, hydroxyethyl starch, is used to precipitate only the red blood cells to obtain leukocyte-rich plasma (LRP). We hypothesized that it might be possible to improve the diagnostic rate of deep mycosis by measuring the BDG content of plasma containing WBC and fungal components and by comparing the BDG content of PRP and LRP measured simultaneously. MATERIALS AND METHODS: Healthy human blood, albumin-added blood, wrung-out gauze fluid-added blood, and fungal solution-added blood were prepared, and PRP and LRP were prepared using hydroxyethyl starch. The BDG content of each sample was measured using the Wako method and compared. In addition, PRP and LRP of fungal-added blood were Gram-stained and examined under a microscope, and the number of WBCs and phagocytosed fungi was counted visually and compared. RESULTS: Measuring the BDG content of LRP confirmed that there were no false positives with LRP, and in vitro experiments comparing albumin-added false-positive blood to fungal-added blood showed significant differences between PRP and LRP only in the fungal-added blood. CONCLUSION: Calculating the BDG-ratio (LRP/PRP) by measuring both LRP and PRP may eliminate false positives and false negatives of true deep mycosis and improve the diagnostic rate. The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2021-03 2021-03-11 /pmc/articles/PMC8032921/ /pubmed/34409781 http://dx.doi.org/10.3947/ic.2020.0128 Text en Copyright © 2021 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Shimoyama, Ken
Kan, Shigenori
Takahashi, Gaku
Morino, Gota
Yamada, Yasuhiko
Inoue, Yoshihiro
Inada, Katsuya
Endo, Shigeatsu
Basic Verification of β-D Glucan in Leukocyte-Rich Plasma for the Diagnosis of Deep Mycosis
title Basic Verification of β-D Glucan in Leukocyte-Rich Plasma for the Diagnosis of Deep Mycosis
title_full Basic Verification of β-D Glucan in Leukocyte-Rich Plasma for the Diagnosis of Deep Mycosis
title_fullStr Basic Verification of β-D Glucan in Leukocyte-Rich Plasma for the Diagnosis of Deep Mycosis
title_full_unstemmed Basic Verification of β-D Glucan in Leukocyte-Rich Plasma for the Diagnosis of Deep Mycosis
title_short Basic Verification of β-D Glucan in Leukocyte-Rich Plasma for the Diagnosis of Deep Mycosis
title_sort basic verification of β-d glucan in leukocyte-rich plasma for the diagnosis of deep mycosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032921/
https://www.ncbi.nlm.nih.gov/pubmed/34409781
http://dx.doi.org/10.3947/ic.2020.0128
work_keys_str_mv AT shimoyamaken basicverificationofbdglucaninleukocyterichplasmaforthediagnosisofdeepmycosis
AT kanshigenori basicverificationofbdglucaninleukocyterichplasmaforthediagnosisofdeepmycosis
AT takahashigaku basicverificationofbdglucaninleukocyterichplasmaforthediagnosisofdeepmycosis
AT morinogota basicverificationofbdglucaninleukocyterichplasmaforthediagnosisofdeepmycosis
AT yamadayasuhiko basicverificationofbdglucaninleukocyterichplasmaforthediagnosisofdeepmycosis
AT inoueyoshihiro basicverificationofbdglucaninleukocyterichplasmaforthediagnosisofdeepmycosis
AT inadakatsuya basicverificationofbdglucaninleukocyterichplasmaforthediagnosisofdeepmycosis
AT endoshigeatsu basicverificationofbdglucaninleukocyterichplasmaforthediagnosisofdeepmycosis